Quarterly ResultMay 6, 2026, 11:58 AM
Gentex Q1 Net Sales $675.4M, Net Income $98.4M; EPS $0.46
AI Summary
Gentex Corporation reported increased net sales and net income for the first quarter of 2026. Net sales grew to $675.4 million, and net income attributable to Gentex Corporation reached $98.4 million, resulting in basic EPS of $0.46. However, the company recognized significant impairment charges totaling $5.5 million related to Vaporsens In-Process R&D and a technology investment, and net cash provided by operating activities decreased compared to the prior year.
Key Highlights
- Net Sales increased to $675.4 million for Q1 2026, up from $576.7 million in Q1 2025.
- Net Income Attributable to Gentex Corporation rose to $98.4 million in Q1 2026 from $94.8 million in Q1 2025.
- Basic Earnings Per Share (EPS) was $0.46 for Q1 2026, compared to $0.42 for Q1 2025.
- The company recorded a $2.8 million impairment charge for Vaporsens In-Process R&D.
- An other-than-temporary impairment charge of $2.7 million was recognized on a technology investment.
- Net cash provided by operating activities was $137.1 million in Q1 2026, down from $148.5 million in Q1 2025.
- Cash and cash equivalents increased to $164.8 million as of March 31, 2026, from $145.6 million at December 31, 2025.
- Common stock repurchases totaled $68.6 million in Q1 2026, compared to $67.8 million in Q1 2025.
Price Impact
More from GNTX